Posts Tagged ‘BioTech’
Healthtech spotlight: Jack Fertility
Jack Fertility has recently launched its £500K fundraising campaign to bring the world’s first home-to-lab sperm test kit to market. We had a chat with Co-founders, Lily Elsner and Nick Shipley, to hear their story… Jack Fertility at a glance: Start date: 2022 Market sector: Healthtech Location: Oxford Number of employees: 3 Amount of funding raised: £125k + government…
Read MoreCell technology spinout Impulsonics closes £450k funding
Impulsonics has closed its first funding round to advance the development of its unique biotech automation platform and begin customer trials. Impulsonics is an award-winning cell technology spinout from the University of Bristol’s Ultrasonics and Non-Destructive Testing Research Group, building on over a decade of deep research and leveraging world-leading expertise in acoustics. The company…
Read MoreBiotech startup Impulsonics awarded £300,000 Innovate UK grant
Bristol-based startup, Impulsonics has been awarded the prestigious ICURe spinout support grant of £300,000 to enable the development of its unique technology platform for biotech automation. The grant will enable the company to develop its flexible acoustic platform for key applications in the process of growing cells in order to streamline cell culture automation. This…
Read MoreActuation Lab secures £3m contract to support decarbonisation with hydrogen
Low carbon hydrogen will be critical to the decarbonisation of the global energy supply. However, hydrogen has an extremely high leak propensity and a global warming potential 12 times greater than carbon dioxide if it escapes into the atmosphere. The risks of ignition associated with hydrogen are significant, particularly in enclosed spaces. To support the…
Read MoreRosa Biotech secures £415,000 to accelerate early disease screening
Bio-sensing pioneer Rosa Biotech has secured £415,000 from angel investors and announced plans to accelerate development of its bio-sensing technology, designed to enable cost effective, early-stage screening of a range of life-threatening diseases. The University of Bristol healthtech spinout joined SETsquared Bristol in February 2023. It is initially targeting the early identification of non-alcoholic fatty…
Read MoreFerryx: Innovative biotech solutions to common gut problems
We had a chat with Dr Jenny Bailey, Co-founder and CEO of Ferryx, to hear her story. The University of Bristol spin-out has recently raised £300k seed capital and been awarded an Innovate Fast Start grant for further development of its innovative solution to common gut problems. Ferryx key facts: Start date: September 2019 Market sector: Healthtech…
Read MoreHealthtech products – from innovation to implementation
There is a vibrant healthtech* cluster in the South West region, with over 90 healthtech startups alone in Bristol. This sector has huge potential for Bristol, but it also has significant market challenges, from how to navigate the NHS to the rapidly evolving international digital regulatory landscape. In this article we share advice for healthtech…
Read MoreBiotech spin-out Ferryx secures seed funding
Bristol-based biotech startup, Ferryx, has raised £300k seed capital from Deepbridge Capital for further development of its innovative solution to common gut problems. Ferryx is a University of Bristol spin-out company that joined SETsquared Bristol in 2020 and has since won ‘Best Elevator Pitch’ at our Tech-Xpo 2021 Showcase. The company aims to tackle the…
Read MoreBiomaterials startup Zentraxa announce seed investment
Our member company and University of Bristol spin-out, Zentraxa, has raised capital investment from Future Planet Capital, BPEC and Science Angel Syndicate to develop their innovative Zentide platform for engineering bespoke biomaterials. With generous support of their recently awarded Innovate UK grant, Zentraxa is rapidly moving towards contracted commercial concept development in both medical adhesives…
Read MoreGenomeKey raise Innovate UK funding to drive life-saving next-gen sepsis diagnostic
Our member GenomeKey, has secured an Innovate UK Biomedical Catalyst research award of £950,000 towards faster diagnosis and treatment of sepsis, one of the world’s most deadly diseases. The funding will enable the Bristol-based research and development company to provide rapid bacterial species identification and antimicrobial profiling in the hospital, which will save lives, save money,…
Read More